Global Immune Response Based POCT Supply, Demand and Key Producers, 2023-2029
The global Immune Response Based POCT market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Immune Response Based POCT demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Immune Response Based POCT, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immune Response Based POCT that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Immune Response Based POCT total market, 2018-2029, (USD Million)
Global Immune Response Based POCT total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Immune Response Based POCT total market, key domestic companies and share, (USD Million)
Global Immune Response Based POCT revenue by player and market share 2018-2023, (USD Million)
Global Immune Response Based POCT total market by Type, CAGR, 2018-2029, (USD Million)
Global Immune Response Based POCT total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Immune Response Based POCT market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, BioMerieux, Wuhan Easy Diagnosis Biomedicine Co.,ltd., Guangzhou Wondfo Biotech Co.,Ltd., Getein Biotech, Inc., Sinocare Inc, Relia Bioengineering Co., Ltd and Beijing Hotgen Biotech Co.,ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Immune Response Based POCT market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Immune Response Based POCT Market, By Region:
1. How big is the global Immune Response Based POCT market?
2. What is the demand of the global Immune Response Based POCT market?
3. What is the year over year growth of the global Immune Response Based POCT market?
4. What is the total value of the global Immune Response Based POCT market?
5. Who are the major players in the global Immune Response Based POCT market?
6. What are the growth factors driving the market demand?
This report studies the global Immune Response Based POCT demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Immune Response Based POCT, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immune Response Based POCT that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Immune Response Based POCT total market, 2018-2029, (USD Million)
Global Immune Response Based POCT total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Immune Response Based POCT total market, key domestic companies and share, (USD Million)
Global Immune Response Based POCT revenue by player and market share 2018-2023, (USD Million)
Global Immune Response Based POCT total market by Type, CAGR, 2018-2029, (USD Million)
Global Immune Response Based POCT total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Immune Response Based POCT market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, BioMerieux, Wuhan Easy Diagnosis Biomedicine Co.,ltd., Guangzhou Wondfo Biotech Co.,Ltd., Getein Biotech, Inc., Sinocare Inc, Relia Bioengineering Co., Ltd and Beijing Hotgen Biotech Co.,ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Immune Response Based POCT market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Immune Response Based POCT Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Immunofiltration Technique
- Immunochromatographic Technique
- Blood Sugar Testing
- Pregnancy Testing
- Tumor Testing
- Infectious Disease Testing
- Drug Abuse Testing
- Other
- Roche
- Abbott
- BioMerieux
- Wuhan Easy Diagnosis Biomedicine Co.,ltd.
- Guangzhou Wondfo Biotech Co.,Ltd.
- Getein Biotech, Inc.
- Sinocare Inc
- Relia Bioengineering Co., Ltd
- Beijing Hotgen Biotech Co.,ltd.
- Assure Tech (Hangzhou) Co.,Ltd.
- Nanjing Vazyme Biotech Co.,Ltd.
- Siemens Healthineers
- Danaher
- Sansure Biotech Inc.
- BD
- Beijing Wantai BioPharm
1. How big is the global Immune Response Based POCT market?
2. What is the demand of the global Immune Response Based POCT market?
3. What is the year over year growth of the global Immune Response Based POCT market?
4. What is the total value of the global Immune Response Based POCT market?
5. Who are the major players in the global Immune Response Based POCT market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Immune Response Based POCT Introduction
1.2 World Immune Response Based POCT Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Immune Response Based POCT Total Market by Region (by Headquarter Location)
1.3.1 World Immune Response Based POCT Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Immune Response Based POCT Market Size (2018-2029)
1.3.3 China Immune Response Based POCT Market Size (2018-2029)
1.3.4 Europe Immune Response Based POCT Market Size (2018-2029)
1.3.5 Japan Immune Response Based POCT Market Size (2018-2029)
1.3.6 South Korea Immune Response Based POCT Market Size (2018-2029)
1.3.7 ASEAN Immune Response Based POCT Market Size (2018-2029)
1.3.8 India Immune Response Based POCT Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immune Response Based POCT Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Immune Response Based POCT Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Immune Response Based POCT Consumption Value (2018-2029)
2.2 World Immune Response Based POCT Consumption Value by Region
2.2.1 World Immune Response Based POCT Consumption Value by Region (2018-2023)
2.2.2 World Immune Response Based POCT Consumption Value Forecast by Region (2024-2029)
2.3 United States Immune Response Based POCT Consumption Value (2018-2029)
2.4 China Immune Response Based POCT Consumption Value (2018-2029)
2.5 Europe Immune Response Based POCT Consumption Value (2018-2029)
2.6 Japan Immune Response Based POCT Consumption Value (2018-2029)
2.7 South Korea Immune Response Based POCT Consumption Value (2018-2029)
2.8 ASEAN Immune Response Based POCT Consumption Value (2018-2029)
2.9 India Immune Response Based POCT Consumption Value (2018-2029)
3 WORLD IMMUNE RESPONSE BASED POCT COMPANIES COMPETITIVE ANALYSIS
3.1 World Immune Response Based POCT Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Immune Response Based POCT Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Immune Response Based POCT in 2022
3.2.3 Global Concentration Ratios (CR8) for Immune Response Based POCT in 2022
3.3 Immune Response Based POCT Company Evaluation Quadrant
3.4 Immune Response Based POCT Market: Overall Company Footprint Analysis
3.4.1 Immune Response Based POCT Market: Region Footprint
3.4.2 Immune Response Based POCT Market: Company Product Type Footprint
3.4.3 Immune Response Based POCT Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Immune Response Based POCT Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Immune Response Based POCT Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Immune Response Based POCT Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Immune Response Based POCT Consumption Value Comparison
4.2.1 United States VS China: Immune Response Based POCT Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Immune Response Based POCT Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Immune Response Based POCT Companies and Market Share, 2018-2023
4.3.1 United States Based Immune Response Based POCT Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Immune Response Based POCT Revenue, (2018-2023)
4.4 China Based Companies Immune Response Based POCT Revenue and Market Share, 2018-2023
4.4.1 China Based Immune Response Based POCT Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Immune Response Based POCT Revenue, (2018-2023)
4.5 Rest of World Based Immune Response Based POCT Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Immune Response Based POCT Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Immune Response Based POCT Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Immune Response Based POCT Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Immunofiltration Technique
5.2.2 Immunochromatographic Technique
5.3 Market Segment by Type
5.3.1 World Immune Response Based POCT Market Size by Type (2018-2023)
5.3.2 World Immune Response Based POCT Market Size by Type (2024-2029)
5.3.3 World Immune Response Based POCT Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Immune Response Based POCT Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Blood Sugar Testing
6.2.2 Pregnancy Testing
6.2.3 Tumor Testing
6.2.4 Infectious Disease Testing
6.2.5 Infectious Disease Testing
6.2.6 Other
6.3 Market Segment by Application
6.3.1 World Immune Response Based POCT Market Size by Application (2018-2023)
6.3.2 World Immune Response Based POCT Market Size by Application (2024-2029)
6.3.3 World Immune Response Based POCT Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Immune Response Based POCT Product and Services
7.1.4 Roche Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Abbott
7.2.1 Abbott Details
7.2.2 Abbott Major Business
7.2.3 Abbott Immune Response Based POCT Product and Services
7.2.4 Abbott Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abbott Recent Developments/Updates
7.2.6 Abbott Competitive Strengths & Weaknesses
7.3 BioMerieux
7.3.1 BioMerieux Details
7.3.2 BioMerieux Major Business
7.3.3 BioMerieux Immune Response Based POCT Product and Services
7.3.4 BioMerieux Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BioMerieux Recent Developments/Updates
7.3.6 BioMerieux Competitive Strengths & Weaknesses
7.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
7.4.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Details
7.4.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
7.4.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Immune Response Based POCT Product and Services
7.4.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
7.4.6 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Competitive Strengths & Weaknesses
7.5 Guangzhou Wondfo Biotech Co.,Ltd.
7.5.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
7.5.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
7.5.3 Guangzhou Wondfo Biotech Co.,Ltd. Immune Response Based POCT Product and Services
7.5.4 Guangzhou Wondfo Biotech Co.,Ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
7.5.6 Guangzhou Wondfo Biotech Co.,Ltd. Competitive Strengths & Weaknesses
7.6 Getein Biotech, Inc.
7.6.1 Getein Biotech, Inc. Details
7.6.2 Getein Biotech, Inc. Major Business
7.6.3 Getein Biotech, Inc. Immune Response Based POCT Product and Services
7.6.4 Getein Biotech, Inc. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Getein Biotech, Inc. Recent Developments/Updates
7.6.6 Getein Biotech, Inc. Competitive Strengths & Weaknesses
7.7 Sinocare Inc
7.7.1 Sinocare Inc Details
7.7.2 Sinocare Inc Major Business
7.7.3 Sinocare Inc Immune Response Based POCT Product and Services
7.7.4 Sinocare Inc Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Sinocare Inc Recent Developments/Updates
7.7.6 Sinocare Inc Competitive Strengths & Weaknesses
7.8 Relia Bioengineering Co., Ltd
7.8.1 Relia Bioengineering Co., Ltd Details
7.8.2 Relia Bioengineering Co., Ltd Major Business
7.8.3 Relia Bioengineering Co., Ltd Immune Response Based POCT Product and Services
7.8.4 Relia Bioengineering Co., Ltd Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Relia Bioengineering Co., Ltd Recent Developments/Updates
7.8.6 Relia Bioengineering Co., Ltd Competitive Strengths & Weaknesses
7.9 Beijing Hotgen Biotech Co.,ltd.
7.9.1 Beijing Hotgen Biotech Co.,ltd. Details
7.9.2 Beijing Hotgen Biotech Co.,ltd. Major Business
7.9.3 Beijing Hotgen Biotech Co.,ltd. Immune Response Based POCT Product and Services
7.9.4 Beijing Hotgen Biotech Co.,ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
7.9.6 Beijing Hotgen Biotech Co.,ltd. Competitive Strengths & Weaknesses
7.10 Assure Tech (Hangzhou) Co.,Ltd.
7.10.1 Assure Tech (Hangzhou) Co.,Ltd. Details
7.10.2 Assure Tech (Hangzhou) Co.,Ltd. Major Business
7.10.3 Assure Tech (Hangzhou) Co.,Ltd. Immune Response Based POCT Product and Services
7.10.4 Assure Tech (Hangzhou) Co.,Ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
7.10.6 Assure Tech (Hangzhou) Co.,Ltd. Competitive Strengths & Weaknesses
7.11 Nanjing Vazyme Biotech Co.,Ltd.
7.11.1 Nanjing Vazyme Biotech Co.,Ltd. Details
7.11.2 Nanjing Vazyme Biotech Co.,Ltd. Major Business
7.11.3 Nanjing Vazyme Biotech Co.,Ltd. Immune Response Based POCT Product and Services
7.11.4 Nanjing Vazyme Biotech Co.,Ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Nanjing Vazyme Biotech Co.,Ltd. Recent Developments/Updates
7.11.6 Nanjing Vazyme Biotech Co.,Ltd. Competitive Strengths & Weaknesses
7.12 Siemens Healthineers
7.12.1 Siemens Healthineers Details
7.12.2 Siemens Healthineers Major Business
7.12.3 Siemens Healthineers Immune Response Based POCT Product and Services
7.12.4 Siemens Healthineers Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Siemens Healthineers Recent Developments/Updates
7.12.6 Siemens Healthineers Competitive Strengths & Weaknesses
7.13 Danaher
7.13.1 Danaher Details
7.13.2 Danaher Major Business
7.13.3 Danaher Immune Response Based POCT Product and Services
7.13.4 Danaher Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Danaher Recent Developments/Updates
7.13.6 Danaher Competitive Strengths & Weaknesses
7.14 Sansure Biotech Inc.
7.14.1 Sansure Biotech Inc. Details
7.14.2 Sansure Biotech Inc. Major Business
7.14.3 Sansure Biotech Inc. Immune Response Based POCT Product and Services
7.14.4 Sansure Biotech Inc. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Sansure Biotech Inc. Recent Developments/Updates
7.14.6 Sansure Biotech Inc. Competitive Strengths & Weaknesses
7.15 BD
7.15.1 BD Details
7.15.2 BD Major Business
7.15.3 BD Immune Response Based POCT Product and Services
7.15.4 BD Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 BD Recent Developments/Updates
7.15.6 BD Competitive Strengths & Weaknesses
7.16 Beijing Wantai BioPharm
7.16.1 Beijing Wantai BioPharm Details
7.16.2 Beijing Wantai BioPharm Major Business
7.16.3 Beijing Wantai BioPharm Immune Response Based POCT Product and Services
7.16.4 Beijing Wantai BioPharm Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Beijing Wantai BioPharm Recent Developments/Updates
7.16.6 Beijing Wantai BioPharm Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Immune Response Based POCT Industry Chain
8.2 Immune Response Based POCT Upstream Analysis
8.3 Immune Response Based POCT Midstream Analysis
8.4 Immune Response Based POCT Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Immune Response Based POCT Introduction
1.2 World Immune Response Based POCT Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Immune Response Based POCT Total Market by Region (by Headquarter Location)
1.3.1 World Immune Response Based POCT Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Immune Response Based POCT Market Size (2018-2029)
1.3.3 China Immune Response Based POCT Market Size (2018-2029)
1.3.4 Europe Immune Response Based POCT Market Size (2018-2029)
1.3.5 Japan Immune Response Based POCT Market Size (2018-2029)
1.3.6 South Korea Immune Response Based POCT Market Size (2018-2029)
1.3.7 ASEAN Immune Response Based POCT Market Size (2018-2029)
1.3.8 India Immune Response Based POCT Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immune Response Based POCT Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Immune Response Based POCT Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Immune Response Based POCT Consumption Value (2018-2029)
2.2 World Immune Response Based POCT Consumption Value by Region
2.2.1 World Immune Response Based POCT Consumption Value by Region (2018-2023)
2.2.2 World Immune Response Based POCT Consumption Value Forecast by Region (2024-2029)
2.3 United States Immune Response Based POCT Consumption Value (2018-2029)
2.4 China Immune Response Based POCT Consumption Value (2018-2029)
2.5 Europe Immune Response Based POCT Consumption Value (2018-2029)
2.6 Japan Immune Response Based POCT Consumption Value (2018-2029)
2.7 South Korea Immune Response Based POCT Consumption Value (2018-2029)
2.8 ASEAN Immune Response Based POCT Consumption Value (2018-2029)
2.9 India Immune Response Based POCT Consumption Value (2018-2029)
3 WORLD IMMUNE RESPONSE BASED POCT COMPANIES COMPETITIVE ANALYSIS
3.1 World Immune Response Based POCT Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Immune Response Based POCT Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Immune Response Based POCT in 2022
3.2.3 Global Concentration Ratios (CR8) for Immune Response Based POCT in 2022
3.3 Immune Response Based POCT Company Evaluation Quadrant
3.4 Immune Response Based POCT Market: Overall Company Footprint Analysis
3.4.1 Immune Response Based POCT Market: Region Footprint
3.4.2 Immune Response Based POCT Market: Company Product Type Footprint
3.4.3 Immune Response Based POCT Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Immune Response Based POCT Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Immune Response Based POCT Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Immune Response Based POCT Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Immune Response Based POCT Consumption Value Comparison
4.2.1 United States VS China: Immune Response Based POCT Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Immune Response Based POCT Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Immune Response Based POCT Companies and Market Share, 2018-2023
4.3.1 United States Based Immune Response Based POCT Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Immune Response Based POCT Revenue, (2018-2023)
4.4 China Based Companies Immune Response Based POCT Revenue and Market Share, 2018-2023
4.4.1 China Based Immune Response Based POCT Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Immune Response Based POCT Revenue, (2018-2023)
4.5 Rest of World Based Immune Response Based POCT Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Immune Response Based POCT Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Immune Response Based POCT Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Immune Response Based POCT Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Immunofiltration Technique
5.2.2 Immunochromatographic Technique
5.3 Market Segment by Type
5.3.1 World Immune Response Based POCT Market Size by Type (2018-2023)
5.3.2 World Immune Response Based POCT Market Size by Type (2024-2029)
5.3.3 World Immune Response Based POCT Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Immune Response Based POCT Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Blood Sugar Testing
6.2.2 Pregnancy Testing
6.2.3 Tumor Testing
6.2.4 Infectious Disease Testing
6.2.5 Infectious Disease Testing
6.2.6 Other
6.3 Market Segment by Application
6.3.1 World Immune Response Based POCT Market Size by Application (2018-2023)
6.3.2 World Immune Response Based POCT Market Size by Application (2024-2029)
6.3.3 World Immune Response Based POCT Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Immune Response Based POCT Product and Services
7.1.4 Roche Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Abbott
7.2.1 Abbott Details
7.2.2 Abbott Major Business
7.2.3 Abbott Immune Response Based POCT Product and Services
7.2.4 Abbott Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abbott Recent Developments/Updates
7.2.6 Abbott Competitive Strengths & Weaknesses
7.3 BioMerieux
7.3.1 BioMerieux Details
7.3.2 BioMerieux Major Business
7.3.3 BioMerieux Immune Response Based POCT Product and Services
7.3.4 BioMerieux Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BioMerieux Recent Developments/Updates
7.3.6 BioMerieux Competitive Strengths & Weaknesses
7.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
7.4.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Details
7.4.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
7.4.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Immune Response Based POCT Product and Services
7.4.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
7.4.6 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Competitive Strengths & Weaknesses
7.5 Guangzhou Wondfo Biotech Co.,Ltd.
7.5.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
7.5.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
7.5.3 Guangzhou Wondfo Biotech Co.,Ltd. Immune Response Based POCT Product and Services
7.5.4 Guangzhou Wondfo Biotech Co.,Ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
7.5.6 Guangzhou Wondfo Biotech Co.,Ltd. Competitive Strengths & Weaknesses
7.6 Getein Biotech, Inc.
7.6.1 Getein Biotech, Inc. Details
7.6.2 Getein Biotech, Inc. Major Business
7.6.3 Getein Biotech, Inc. Immune Response Based POCT Product and Services
7.6.4 Getein Biotech, Inc. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Getein Biotech, Inc. Recent Developments/Updates
7.6.6 Getein Biotech, Inc. Competitive Strengths & Weaknesses
7.7 Sinocare Inc
7.7.1 Sinocare Inc Details
7.7.2 Sinocare Inc Major Business
7.7.3 Sinocare Inc Immune Response Based POCT Product and Services
7.7.4 Sinocare Inc Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Sinocare Inc Recent Developments/Updates
7.7.6 Sinocare Inc Competitive Strengths & Weaknesses
7.8 Relia Bioengineering Co., Ltd
7.8.1 Relia Bioengineering Co., Ltd Details
7.8.2 Relia Bioengineering Co., Ltd Major Business
7.8.3 Relia Bioengineering Co., Ltd Immune Response Based POCT Product and Services
7.8.4 Relia Bioengineering Co., Ltd Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Relia Bioengineering Co., Ltd Recent Developments/Updates
7.8.6 Relia Bioengineering Co., Ltd Competitive Strengths & Weaknesses
7.9 Beijing Hotgen Biotech Co.,ltd.
7.9.1 Beijing Hotgen Biotech Co.,ltd. Details
7.9.2 Beijing Hotgen Biotech Co.,ltd. Major Business
7.9.3 Beijing Hotgen Biotech Co.,ltd. Immune Response Based POCT Product and Services
7.9.4 Beijing Hotgen Biotech Co.,ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
7.9.6 Beijing Hotgen Biotech Co.,ltd. Competitive Strengths & Weaknesses
7.10 Assure Tech (Hangzhou) Co.,Ltd.
7.10.1 Assure Tech (Hangzhou) Co.,Ltd. Details
7.10.2 Assure Tech (Hangzhou) Co.,Ltd. Major Business
7.10.3 Assure Tech (Hangzhou) Co.,Ltd. Immune Response Based POCT Product and Services
7.10.4 Assure Tech (Hangzhou) Co.,Ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
7.10.6 Assure Tech (Hangzhou) Co.,Ltd. Competitive Strengths & Weaknesses
7.11 Nanjing Vazyme Biotech Co.,Ltd.
7.11.1 Nanjing Vazyme Biotech Co.,Ltd. Details
7.11.2 Nanjing Vazyme Biotech Co.,Ltd. Major Business
7.11.3 Nanjing Vazyme Biotech Co.,Ltd. Immune Response Based POCT Product and Services
7.11.4 Nanjing Vazyme Biotech Co.,Ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Nanjing Vazyme Biotech Co.,Ltd. Recent Developments/Updates
7.11.6 Nanjing Vazyme Biotech Co.,Ltd. Competitive Strengths & Weaknesses
7.12 Siemens Healthineers
7.12.1 Siemens Healthineers Details
7.12.2 Siemens Healthineers Major Business
7.12.3 Siemens Healthineers Immune Response Based POCT Product and Services
7.12.4 Siemens Healthineers Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Siemens Healthineers Recent Developments/Updates
7.12.6 Siemens Healthineers Competitive Strengths & Weaknesses
7.13 Danaher
7.13.1 Danaher Details
7.13.2 Danaher Major Business
7.13.3 Danaher Immune Response Based POCT Product and Services
7.13.4 Danaher Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Danaher Recent Developments/Updates
7.13.6 Danaher Competitive Strengths & Weaknesses
7.14 Sansure Biotech Inc.
7.14.1 Sansure Biotech Inc. Details
7.14.2 Sansure Biotech Inc. Major Business
7.14.3 Sansure Biotech Inc. Immune Response Based POCT Product and Services
7.14.4 Sansure Biotech Inc. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Sansure Biotech Inc. Recent Developments/Updates
7.14.6 Sansure Biotech Inc. Competitive Strengths & Weaknesses
7.15 BD
7.15.1 BD Details
7.15.2 BD Major Business
7.15.3 BD Immune Response Based POCT Product and Services
7.15.4 BD Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 BD Recent Developments/Updates
7.15.6 BD Competitive Strengths & Weaknesses
7.16 Beijing Wantai BioPharm
7.16.1 Beijing Wantai BioPharm Details
7.16.2 Beijing Wantai BioPharm Major Business
7.16.3 Beijing Wantai BioPharm Immune Response Based POCT Product and Services
7.16.4 Beijing Wantai BioPharm Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Beijing Wantai BioPharm Recent Developments/Updates
7.16.6 Beijing Wantai BioPharm Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Immune Response Based POCT Industry Chain
8.2 Immune Response Based POCT Upstream Analysis
8.3 Immune Response Based POCT Midstream Analysis
8.4 Immune Response Based POCT Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Immune Response Based POCT Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Immune Response Based POCT Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Immune Response Based POCT Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Immune Response Based POCT Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Immune Response Based POCT Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Immune Response Based POCT Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Immune Response Based POCT Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Immune Response Based POCT Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Immune Response Based POCT Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Immune Response Based POCT Players in 2022
Table 12. World Immune Response Based POCT Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Immune Response Based POCT Company Evaluation Quadrant
Table 14. Head Office of Key Immune Response Based POCT Player
Table 15. Immune Response Based POCT Market: Company Product Type Footprint
Table 16. Immune Response Based POCT Market: Company Product Application Footprint
Table 17. Immune Response Based POCT Mergers & Acquisitions Activity
Table 18. United States VS China Immune Response Based POCT Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Immune Response Based POCT Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Immune Response Based POCT Companies, Headquarters (States, Country)
Table 21. United States Based Companies Immune Response Based POCT Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Immune Response Based POCT Revenue Market Share (2018-2023)
Table 23. China Based Immune Response Based POCT Companies, Headquarters (Province, Country)
Table 24. China Based Companies Immune Response Based POCT Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Immune Response Based POCT Revenue Market Share (2018-2023)
Table 26. Rest of World Based Immune Response Based POCT Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Immune Response Based POCT Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Immune Response Based POCT Revenue Market Share (2018-2023)
Table 29. World Immune Response Based POCT Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Immune Response Based POCT Market Size by Type (2018-2023) & (USD Million)
Table 31. World Immune Response Based POCT Market Size by Type (2024-2029) & (USD Million)
Table 32. World Immune Response Based POCT Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Immune Response Based POCT Market Size by Application (2018-2023) & (USD Million)
Table 34. World Immune Response Based POCT Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche Immune Response Based POCT Product and Services
Table 38. Roche Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Abbott Basic Information, Area Served and Competitors
Table 42. Abbott Major Business
Table 43. Abbott Immune Response Based POCT Product and Services
Table 44. Abbott Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abbott Recent Developments/Updates
Table 46. Abbott Competitive Strengths & Weaknesses
Table 47. BioMerieux Basic Information, Area Served and Competitors
Table 48. BioMerieux Major Business
Table 49. BioMerieux Immune Response Based POCT Product and Services
Table 50. BioMerieux Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BioMerieux Recent Developments/Updates
Table 52. BioMerieux Competitive Strengths & Weaknesses
Table 53. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Basic Information, Area Served and Competitors
Table 54. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
Table 55. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Immune Response Based POCT Product and Services
Table 56. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
Table 58. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Competitive Strengths & Weaknesses
Table 59. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Area Served and Competitors
Table 60. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 61. Guangzhou Wondfo Biotech Co.,Ltd. Immune Response Based POCT Product and Services
Table 62. Guangzhou Wondfo Biotech Co.,Ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 64. Guangzhou Wondfo Biotech Co.,Ltd. Competitive Strengths & Weaknesses
Table 65. Getein Biotech, Inc. Basic Information, Area Served and Competitors
Table 66. Getein Biotech, Inc. Major Business
Table 67. Getein Biotech, Inc. Immune Response Based POCT Product and Services
Table 68. Getein Biotech, Inc. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Getein Biotech, Inc. Recent Developments/Updates
Table 70. Getein Biotech, Inc. Competitive Strengths & Weaknesses
Table 71. Sinocare Inc Basic Information, Area Served and Competitors
Table 72. Sinocare Inc Major Business
Table 73. Sinocare Inc Immune Response Based POCT Product and Services
Table 74. Sinocare Inc Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Sinocare Inc Recent Developments/Updates
Table 76. Sinocare Inc Competitive Strengths & Weaknesses
Table 77. Relia Bioengineering Co., Ltd Basic Information, Area Served and Competitors
Table 78. Relia Bioengineering Co., Ltd Major Business
Table 79. Relia Bioengineering Co., Ltd Immune Response Based POCT Product and Services
Table 80. Relia Bioengineering Co., Ltd Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Relia Bioengineering Co., Ltd Recent Developments/Updates
Table 82. Relia Bioengineering Co., Ltd Competitive Strengths & Weaknesses
Table 83. Beijing Hotgen Biotech Co.,ltd. Basic Information, Area Served and Competitors
Table 84. Beijing Hotgen Biotech Co.,ltd. Major Business
Table 85. Beijing Hotgen Biotech Co.,ltd. Immune Response Based POCT Product and Services
Table 86. Beijing Hotgen Biotech Co.,ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
Table 88. Beijing Hotgen Biotech Co.,ltd. Competitive Strengths & Weaknesses
Table 89. Assure Tech (Hangzhou) Co.,Ltd. Basic Information, Area Served and Competitors
Table 90. Assure Tech (Hangzhou) Co.,Ltd. Major Business
Table 91. Assure Tech (Hangzhou) Co.,Ltd. Immune Response Based POCT Product and Services
Table 92. Assure Tech (Hangzhou) Co.,Ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
Table 94. Assure Tech (Hangzhou) Co.,Ltd. Competitive Strengths & Weaknesses
Table 95. Nanjing Vazyme Biotech Co.,Ltd. Basic Information, Area Served and Competitors
Table 96. Nanjing Vazyme Biotech Co.,Ltd. Major Business
Table 97. Nanjing Vazyme Biotech Co.,Ltd. Immune Response Based POCT Product and Services
Table 98. Nanjing Vazyme Biotech Co.,Ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Nanjing Vazyme Biotech Co.,Ltd. Recent Developments/Updates
Table 100. Nanjing Vazyme Biotech Co.,Ltd. Competitive Strengths & Weaknesses
Table 101. Siemens Healthineers Basic Information, Area Served and Competitors
Table 102. Siemens Healthineers Major Business
Table 103. Siemens Healthineers Immune Response Based POCT Product and Services
Table 104. Siemens Healthineers Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Siemens Healthineers Recent Developments/Updates
Table 106. Siemens Healthineers Competitive Strengths & Weaknesses
Table 107. Danaher Basic Information, Area Served and Competitors
Table 108. Danaher Major Business
Table 109. Danaher Immune Response Based POCT Product and Services
Table 110. Danaher Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Danaher Recent Developments/Updates
Table 112. Danaher Competitive Strengths & Weaknesses
Table 113. Sansure Biotech Inc. Basic Information, Area Served and Competitors
Table 114. Sansure Biotech Inc. Major Business
Table 115. Sansure Biotech Inc. Immune Response Based POCT Product and Services
Table 116. Sansure Biotech Inc. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Sansure Biotech Inc. Recent Developments/Updates
Table 118. Sansure Biotech Inc. Competitive Strengths & Weaknesses
Table 119. BD Basic Information, Area Served and Competitors
Table 120. BD Major Business
Table 121. BD Immune Response Based POCT Product and Services
Table 122. BD Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. BD Recent Developments/Updates
Table 124. Beijing Wantai BioPharm Basic Information, Area Served and Competitors
Table 125. Beijing Wantai BioPharm Major Business
Table 126. Beijing Wantai BioPharm Immune Response Based POCT Product and Services
Table 127. Beijing Wantai BioPharm Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 128. Global Key Players of Immune Response Based POCT Upstream (Raw Materials)
Table 129. Immune Response Based POCT Typical Customers
Table 1. World Immune Response Based POCT Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Immune Response Based POCT Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Immune Response Based POCT Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Immune Response Based POCT Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Immune Response Based POCT Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Immune Response Based POCT Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Immune Response Based POCT Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Immune Response Based POCT Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Immune Response Based POCT Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Immune Response Based POCT Players in 2022
Table 12. World Immune Response Based POCT Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Immune Response Based POCT Company Evaluation Quadrant
Table 14. Head Office of Key Immune Response Based POCT Player
Table 15. Immune Response Based POCT Market: Company Product Type Footprint
Table 16. Immune Response Based POCT Market: Company Product Application Footprint
Table 17. Immune Response Based POCT Mergers & Acquisitions Activity
Table 18. United States VS China Immune Response Based POCT Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Immune Response Based POCT Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Immune Response Based POCT Companies, Headquarters (States, Country)
Table 21. United States Based Companies Immune Response Based POCT Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Immune Response Based POCT Revenue Market Share (2018-2023)
Table 23. China Based Immune Response Based POCT Companies, Headquarters (Province, Country)
Table 24. China Based Companies Immune Response Based POCT Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Immune Response Based POCT Revenue Market Share (2018-2023)
Table 26. Rest of World Based Immune Response Based POCT Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Immune Response Based POCT Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Immune Response Based POCT Revenue Market Share (2018-2023)
Table 29. World Immune Response Based POCT Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Immune Response Based POCT Market Size by Type (2018-2023) & (USD Million)
Table 31. World Immune Response Based POCT Market Size by Type (2024-2029) & (USD Million)
Table 32. World Immune Response Based POCT Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Immune Response Based POCT Market Size by Application (2018-2023) & (USD Million)
Table 34. World Immune Response Based POCT Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche Immune Response Based POCT Product and Services
Table 38. Roche Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Abbott Basic Information, Area Served and Competitors
Table 42. Abbott Major Business
Table 43. Abbott Immune Response Based POCT Product and Services
Table 44. Abbott Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abbott Recent Developments/Updates
Table 46. Abbott Competitive Strengths & Weaknesses
Table 47. BioMerieux Basic Information, Area Served and Competitors
Table 48. BioMerieux Major Business
Table 49. BioMerieux Immune Response Based POCT Product and Services
Table 50. BioMerieux Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BioMerieux Recent Developments/Updates
Table 52. BioMerieux Competitive Strengths & Weaknesses
Table 53. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Basic Information, Area Served and Competitors
Table 54. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
Table 55. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Immune Response Based POCT Product and Services
Table 56. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
Table 58. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Competitive Strengths & Weaknesses
Table 59. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Area Served and Competitors
Table 60. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 61. Guangzhou Wondfo Biotech Co.,Ltd. Immune Response Based POCT Product and Services
Table 62. Guangzhou Wondfo Biotech Co.,Ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 64. Guangzhou Wondfo Biotech Co.,Ltd. Competitive Strengths & Weaknesses
Table 65. Getein Biotech, Inc. Basic Information, Area Served and Competitors
Table 66. Getein Biotech, Inc. Major Business
Table 67. Getein Biotech, Inc. Immune Response Based POCT Product and Services
Table 68. Getein Biotech, Inc. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Getein Biotech, Inc. Recent Developments/Updates
Table 70. Getein Biotech, Inc. Competitive Strengths & Weaknesses
Table 71. Sinocare Inc Basic Information, Area Served and Competitors
Table 72. Sinocare Inc Major Business
Table 73. Sinocare Inc Immune Response Based POCT Product and Services
Table 74. Sinocare Inc Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Sinocare Inc Recent Developments/Updates
Table 76. Sinocare Inc Competitive Strengths & Weaknesses
Table 77. Relia Bioengineering Co., Ltd Basic Information, Area Served and Competitors
Table 78. Relia Bioengineering Co., Ltd Major Business
Table 79. Relia Bioengineering Co., Ltd Immune Response Based POCT Product and Services
Table 80. Relia Bioengineering Co., Ltd Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Relia Bioengineering Co., Ltd Recent Developments/Updates
Table 82. Relia Bioengineering Co., Ltd Competitive Strengths & Weaknesses
Table 83. Beijing Hotgen Biotech Co.,ltd. Basic Information, Area Served and Competitors
Table 84. Beijing Hotgen Biotech Co.,ltd. Major Business
Table 85. Beijing Hotgen Biotech Co.,ltd. Immune Response Based POCT Product and Services
Table 86. Beijing Hotgen Biotech Co.,ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
Table 88. Beijing Hotgen Biotech Co.,ltd. Competitive Strengths & Weaknesses
Table 89. Assure Tech (Hangzhou) Co.,Ltd. Basic Information, Area Served and Competitors
Table 90. Assure Tech (Hangzhou) Co.,Ltd. Major Business
Table 91. Assure Tech (Hangzhou) Co.,Ltd. Immune Response Based POCT Product and Services
Table 92. Assure Tech (Hangzhou) Co.,Ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
Table 94. Assure Tech (Hangzhou) Co.,Ltd. Competitive Strengths & Weaknesses
Table 95. Nanjing Vazyme Biotech Co.,Ltd. Basic Information, Area Served and Competitors
Table 96. Nanjing Vazyme Biotech Co.,Ltd. Major Business
Table 97. Nanjing Vazyme Biotech Co.,Ltd. Immune Response Based POCT Product and Services
Table 98. Nanjing Vazyme Biotech Co.,Ltd. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Nanjing Vazyme Biotech Co.,Ltd. Recent Developments/Updates
Table 100. Nanjing Vazyme Biotech Co.,Ltd. Competitive Strengths & Weaknesses
Table 101. Siemens Healthineers Basic Information, Area Served and Competitors
Table 102. Siemens Healthineers Major Business
Table 103. Siemens Healthineers Immune Response Based POCT Product and Services
Table 104. Siemens Healthineers Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Siemens Healthineers Recent Developments/Updates
Table 106. Siemens Healthineers Competitive Strengths & Weaknesses
Table 107. Danaher Basic Information, Area Served and Competitors
Table 108. Danaher Major Business
Table 109. Danaher Immune Response Based POCT Product and Services
Table 110. Danaher Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Danaher Recent Developments/Updates
Table 112. Danaher Competitive Strengths & Weaknesses
Table 113. Sansure Biotech Inc. Basic Information, Area Served and Competitors
Table 114. Sansure Biotech Inc. Major Business
Table 115. Sansure Biotech Inc. Immune Response Based POCT Product and Services
Table 116. Sansure Biotech Inc. Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Sansure Biotech Inc. Recent Developments/Updates
Table 118. Sansure Biotech Inc. Competitive Strengths & Weaknesses
Table 119. BD Basic Information, Area Served and Competitors
Table 120. BD Major Business
Table 121. BD Immune Response Based POCT Product and Services
Table 122. BD Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. BD Recent Developments/Updates
Table 124. Beijing Wantai BioPharm Basic Information, Area Served and Competitors
Table 125. Beijing Wantai BioPharm Major Business
Table 126. Beijing Wantai BioPharm Immune Response Based POCT Product and Services
Table 127. Beijing Wantai BioPharm Immune Response Based POCT Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 128. Global Key Players of Immune Response Based POCT Upstream (Raw Materials)
Table 129. Immune Response Based POCT Typical Customers
LIST OF FIGURES
Figure 1. Immune Response Based POCT Picture
Figure 2. World Immune Response Based POCT Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Immune Response Based POCT Total Market Size (2018-2029) & (USD Million)
Figure 4. World Immune Response Based POCT Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Immune Response Based POCT Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Immune Response Based POCT Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Immune Response Based POCT Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Immune Response Based POCT Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Immune Response Based POCT Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Immune Response Based POCT Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Immune Response Based POCT Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Immune Response Based POCT Revenue (2018-2029) & (USD Million)
Figure 13. Immune Response Based POCT Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 16. World Immune Response Based POCT Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 18. China Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 23. India Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Immune Response Based POCT by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Immune Response Based POCT Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Immune Response Based POCT Markets in 2022
Figure 27. United States VS China: Immune Response Based POCT Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Immune Response Based POCT Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Immune Response Based POCT Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Immune Response Based POCT Market Size Market Share by Type in 2022
Figure 31. Immunofiltration Technique
Figure 32. Immunochromatographic Technique
Figure 33. World Immune Response Based POCT Market Size Market Share by Type (2018-2029)
Figure 34. World Immune Response Based POCT Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Immune Response Based POCT Market Size Market Share by Application in 2022
Figure 36. Blood Sugar Testing
Figure 37. Pregnancy Testing
Figure 38. Tumor Testing
Figure 39. Infectious Disease Testing
Figure 40. Drug Abuse Testing
Figure 41. Other
Figure 42. Immune Response Based POCT Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Immune Response Based POCT Picture
Figure 2. World Immune Response Based POCT Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Immune Response Based POCT Total Market Size (2018-2029) & (USD Million)
Figure 4. World Immune Response Based POCT Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Immune Response Based POCT Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Immune Response Based POCT Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Immune Response Based POCT Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Immune Response Based POCT Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Immune Response Based POCT Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Immune Response Based POCT Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Immune Response Based POCT Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Immune Response Based POCT Revenue (2018-2029) & (USD Million)
Figure 13. Immune Response Based POCT Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 16. World Immune Response Based POCT Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 18. China Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 23. India Immune Response Based POCT Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Immune Response Based POCT by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Immune Response Based POCT Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Immune Response Based POCT Markets in 2022
Figure 27. United States VS China: Immune Response Based POCT Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Immune Response Based POCT Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Immune Response Based POCT Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Immune Response Based POCT Market Size Market Share by Type in 2022
Figure 31. Immunofiltration Technique
Figure 32. Immunochromatographic Technique
Figure 33. World Immune Response Based POCT Market Size Market Share by Type (2018-2029)
Figure 34. World Immune Response Based POCT Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Immune Response Based POCT Market Size Market Share by Application in 2022
Figure 36. Blood Sugar Testing
Figure 37. Pregnancy Testing
Figure 38. Tumor Testing
Figure 39. Infectious Disease Testing
Figure 40. Drug Abuse Testing
Figure 41. Other
Figure 42. Immune Response Based POCT Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
